Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 or 40 mg GA Depot in Subjects With RRMS
Clinical trial NCT02212886 · COMPLETED
Trial details
- NCT number
- NCT02212886
- Sponsor
- Mapi Pharma Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2017-05-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.